{"SPADE_UN_26829": {"Sequence Information": {"Peptide Name": "Ranatuerin R2AW [C23,29S]", "Sequence": "GFMDTAKNVAKNVAATLLDKLKSKITGGS", "Sequence Length": 29, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell", "Antibiofilm"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "G3XHN9", "uniprotUrl": "http://www.uniprot.org/uniprot/G3XHN9", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Progressive Design of a Ranatuerin-2 Peptide from Amolops wuyiensis: Enhancement of Bioactivity and In Vivo Efficacy.", "Pubmed ID": "38275314", "Reference": "Antibiotics (Basel). 2023;13:5", "Author": "Yao A, Liu T, Cai Y, Zhou S, Chen X, Zhou M, Ma C, Chen T, Shaw C, Wang L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/38275314"}], "Mass": 2979.45, "PI": 9.83, "Net Charge": 3, "Hydrophobicity": -0.08, "Frequent Amino Acids": "KAG", "Absent Amino Acids": "CEHOPQRUWY", "Basic Residues": 5, "Acidic Residues": 2, "Hydrophobic Residues": 12, "Polar Residues": 17, "Positive Residues": 5, "Negative Residues": 2, "SPADE ID": "SPADE_UN_26829", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26830", "Similarity": 1.0, "Sequence": "GFMDTAKNVAKNVAATLLDKLK"}, {"SPADE_ID": "SPADE_UN_26831", "Similarity": 1.0, "Sequence": "GFMDTAKNVAKNVAATLLDKLK"}, {"SPADE_ID": "SPADE_N_01146", "Similarity": 0.9310344827586207, "Sequence": "GFMDTAKNVAKNVAATLLDKLKCKITGGC"}], "Hemolytic Activity": "Horse erythrocytes:<5% Hemolysis=128 µM,Horse erythrocytes:10% Hemolysis=256 µM", "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=64µM),Staphylococcus aureus NCTC 10788(MBC=64µM),Escherichia coli ATCC 8739(MIC=64µM),Escherichia coli ATCC 8739(MBC=128µM),Staphylococcus aureus NCTC 12493(MIC=256µM),Staphylococcus aureus NCTC 12493(MBC=512µM),Klebsiella pneumoniae ATCC 43816(MIC=256µM),Klebsiella pneumoniae ATCC 43816(MBC=512µM),Enterococcus faecium NTCC 12697(MIC=256µM),Enterococcus faecium NTCC 12697(MBC=512µM),Pseudomonas aeruginosa ATCC 9027(MIC=512µM),Pseudomonas aeruginosa ATCC 9027(MBC=>512µM),Human lung adenocarcinoma NCI-H838(IC50=19.34µM),Human prostate adenocarcinoma PC-3(IC50=17.44µM),Human glioblastoma U251-MG(IC50=37.31µM),Human breast adenocarcinoma MCF-7(IC50=62.7µM),Human colon adenocarcinoma HCT 116(IC50=31.64µM)"}}}